NuGene International (NUGN) Stock Statistics & Valuation Metrics

NuGene International has a market cap or net worth of $4.83M. The enterprise value is $14.27M.

NuGene International has 1,237,934,600 shares outstanding. The number of shares has decreased by -2.65% in one year.

NuGene International’s return on equity (ROE) is -0.01 and return on invested capital (ROIC) is -4.58%.

The current PE Ratio of NuGene International is -4.73. NuGene International’s PEG ratio is -0.08.

In the last 12 months, NuGene International had revenue of 1.69M and earned -596.39K in profits. Earnings per share was 0.00.

In the last 12 months, operating cash flow was -155.90K and capital expenditures -48.36K, giving a free cash flow of -82.46K billion.

NuGene International pays an annual dividend of ―, resulting in a dividend yield of ―

NuGene International upcoming earnings date is Aug 14, 2023, During Market Hours (Confirmed).

NuGene International as a current ratio of 5.01, with Debt / Equity ratio of 0.31%

In the past 12 months, NuGene International has paid 0.00 in taxes.

NuGene International EV to EBITDA ratio is -59.95, with an EV/FCF ratio of -19.54.

NuGene International has $0.00 in cash and marketable securities with $227.06K in debt, giving a net cash position of $227.06K billion.

Gross margin is -5.34%, with operating margin of -127.52%, and net profit margin of -35.26%.

The average price target for NuGene International is ―, which is 11.43% higher than the current price. The consensus rating is ―